VNRX
VolitionRX Limited
0.70
USD
This page is just a preview of the data found in TrendSpider’s full version
VolitionRX Limited stock is down -19.98% since 30 days ago. The next earnings date is Mar 13, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 46.15% of the previous 12 December’s closed higher than November. 100% of analysts rate it a buy.
VolitionRx Limited engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; NuQ Nets, monitoring the immune system, and NuQ Vet cancer screening test for veterinary applications. The company operates Nucleosomics a technology platform.
